You are using an older browser version. Please use a supported version for the best MSN experience.

Wanted: More high-tech manufacturing space for a global vaccine push

The number of available COVID-19 vaccine doses is steadily rising, but a shortage of physical space that meets standards for pharmaceutical manufacturing is a major bottleneck to further expansion, according to drugmakers, industry construction experts and officials involved in the U.S. vaccine program. Ciara Lee reports.

UP NEXT

UP NEXT

image beaconimage beaconimage beacon